publication venue for
- Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole.. 20. 2019
- Polymorphisms in IGF2/H19 gene locus are associated with platinum-based chemotherapeutic response in Chinese patients with epithelial ovarian cancer.. 20. 2019
- Minimum information required for a DMET experiment reporting.. 17. 2016
- Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.. 16. 2015
- Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.. 16. 2015
- Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients.. 12. 2011
- Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients.. 11. 2010
- Role of CYP2D6 testing in selection of endocrine therapy for breast cancer.. 8. 2007
- Pharmacogenomics and breast cancer. 2004
- The emergence of resistance to targeted cancer therapeutics. 2002
- Pharmacogenetics of etanercept in rheumatoid arthritis. 2008
- Copy number variants and pharmacogenomics. 2006